1. Home
  2. CMRC vs MDWD Comparison

CMRC vs MDWD Comparison

Compare CMRC & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commerce.com Inc.

CMRC

Commerce.com Inc.

HOLD

Current Price

$2.67

Market Cap

211.3M

Sector

N/A

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.11

Market Cap

193.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRC
MDWD
Founded
2009
2000
Country
United States
Israel
Employees
1079
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.3M
193.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CMRC
MDWD
Price
$2.67
$16.11
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$5.50
$36.00
AVG Volume (30 Days)
641.1K
70.7K
Earning Date
05-07-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.27
$48.88
Revenue Next Year
$4.75
$35.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.41
$14.14
52 Week High
$5.55
$22.51

Technical Indicators

Market Signals
Indicator
CMRC
MDWD
Relative Strength Index (RSI) 43.98 43.64
Support Level $2.41 N/A
Resistance Level $3.13 $18.71
Average True Range (ATR) 0.13 0.65
MACD 0.00 -0.13
Stochastic Oscillator 42.16 45.83

Price Performance

Historical Comparison
CMRC
MDWD

About CMRC Commerce.com Inc.

Commerce.com Inc is engaged in offering a Software-as-a-Service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which the majority of its revenue is generated from Americas-U.S.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: